{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-088726","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2026-08-13T12:30:26+00:00","discovered_at":"2026-08-13T12:35:00.374875+00:00","generated_at":"2026-08-13T12:35:27.478722+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SS Innovations Q2 revenue up 39% to $13.9M; net loss widens to $2.7M","bullets":["Revenue $13.9M, +39.4% YoY; gross margin 50.9% vs 59.1% prior year.","Net loss $2.7M ($0.01/share) vs $0.3M loss in Q2 2025.","SSi Mantra installations 30 in Q2 (+30.4%); cumulative base 224 systems, 12,272 surgeries.","H1 revenue $25.0M (+65.6%); net loss $6.2M vs $5.9M.","FDA 510(k) decision expected by end Q1 2027; EU CE mark targeted by end 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-088726","json":"https://secwatch.observer/filing/0001213900-26-088726.json","markdown":"https://secwatch.observer/filing/0001213900-26-088726.md","text":"https://secwatch.observer/filing/0001213900-26-088726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/0001213900-26-088726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026088726/ea0301887-8k_ssinnova.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T12:35:27.478722+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}